Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding
Clinical trial NCT05471505 · COMPLETED
Trial details
- NCT number
- NCT05471505
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-25
- Primary completion
- 2022-09-27
- Enrollment
- 120722
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.